Literature DB >> 5055709

Urinary hydroxyproline excretion in carcinoma of the breast.

A Cuschieri, R A Felgate.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5055709      PMCID: PMC2072461     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


× No keyword cloud information.
  19 in total

1.  Significance of urinary hydroxyproline in man.

Authors:  D J PROCKOP; A SJOERDSMA
Journal:  J Clin Invest       Date:  1961-05       Impact factor: 14.808

2.  The determination of collagen and elastin in tissues.

Authors:  R E NEUMAN; M A LOGAN
Journal:  J Biol Chem       Date:  1950-10       Impact factor: 5.157

3.  Elevated plasma levels of a hydroxyproline-containing protein in Hodgkin's disease and their relation to disease activity.

Authors:  E C Leroy; P P Carbone; A Sjoerdsma
Journal:  J Lab Clin Med       Date:  1966-06

4.  Urinary hydroxyproline excretion in patients with cancer.

Authors:  C E Guzzo; W N Pachas; R S Pinals; M J Krant
Journal:  Cancer       Date:  1969-08       Impact factor: 6.860

5.  The detection of skeletal metastases from carcinoma of the breast.

Authors:  C S Galasko
Journal:  Surg Gynecol Obstet       Date:  1971-06

6.  Detection of osseous metastases. Evaluation of bone scanning with strontium-85.

Authors:  R C Briggs
Journal:  Cancer       Date:  1967-03       Impact factor: 6.860

7.  Urinary hydroxyproline and calcium metabolism in patients with cancer.

Authors:  G Bonadonna; M J Merlino; W P Myers; M Sonenberg
Journal:  N Engl J Med       Date:  1966-08-11       Impact factor: 91.245

8.  Hydroxyproline in the serum and urine. Normal values and clinical significance.

Authors:  O Laitinen; E A Nikkilä; K I Kivirikko
Journal:  Acta Med Scand       Date:  1966-03

9.  Studies with 14C-proline on the action of cortisone on the metabolism of collagen in the rat.

Authors:  K I Kivirikko; O Laitinen; J Aer; J Halme
Journal:  Biochem Pharmacol       Date:  1965-10       Impact factor: 5.858

10.  Hydroxyproline excretion in malignant neoplastic disease.

Authors:  H F Hosley; E G Taft; K B Olson; S Gates; R T Beebe
Journal:  Arch Intern Med       Date:  1966-12
View more
  3 in total

1.  Urinary hydroxyproline in the management of breast cancer.

Authors:  A Cuschieri
Journal:  World J Surg       Date:  1977-05       Impact factor: 3.352

2.  Relevance of hydroxyproline excretion to bone metastasis in breast cancer.

Authors:  F Gielen; J Dequeker; A Drochmans; J Wildiers; M Merlevede
Journal:  Br J Cancer       Date:  1976-09       Impact factor: 7.640

3.  Three-centre study on urinary hydroxyproline excretion in cancer of the breast.

Authors:  A Cuschieri; R Jarvie; W H Taylor; E Cant; C M Furnival; L H Blumgart
Journal:  Br J Cancer       Date:  1978-06       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.